ATE345818T1 - S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen. - Google Patents

S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.

Info

Publication number: ATE345818T1
Authority: AT; Austria
Prior art keywords: ziprasidone; dihydro; methyl; treatment; psychiatric disorders
Prior art date: 2000-06-02

Application number

AT04013380T

Other languages

English (en)

Inventor

Chandra Prakash

Teresa Annette Smolarek

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-02

Filing date

2001-05-28

Publication date

2006-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE345818(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-12-15 Application granted granted Critical

2006-12-15 Publication of ATE345818T1 publication Critical patent/ATE345818T1/de

Links

NHUDBVVEHOSVCD-UHFFFAOYSA-N 6-chloro-5-[2-[4-(2-methylsulfanylbenzenecarboximidoyl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one Chemical compound CSC1=CC=CC=C1C(=N)N1CCN(CCC=2C(=CC=3NC(=O)CC=3C=2)Cl)CC1 NHUDBVVEHOSVCD-UHFFFAOYSA-N 0.000 title 1
208000020016 psychiatric disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

AT04013380T 2000-06-02 2001-05-28 S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen. ATE345818T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20913600P	2000-06-02	2000-06-02
US21217200P	2000-06-16	2000-06-16

Publications (1)

Publication Number	Publication Date
ATE345818T1 true ATE345818T1 (de)	2006-12-15

Family

ID=26903852

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT01932011T ATE343387T1 (de)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
AT06116051T ATE391507T1 (de)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidone für die behandlung von schizophrenie
AT04013380T ATE345818T1 (de)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
AT01932011T ATE343387T1 (de)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
AT06116051T ATE391507T1 (de)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidone für die behandlung von schizophrenie

Country Status (44)

Country	Link
US (1)	US20060287336A1 (de)
EP (3)	EP1286672B1 (de)
JP (2)	JP2003534381A (de)
KR (1)	KR20030007824A (de)
CN (1)	CN1431901A (de)
AP (2)	AP1831A (de)
AR (1)	AR028937A1 (de)
AT (3)	ATE343387T1 (de)
AU (1)	AU2001258690A1 (de)
BG (1)	BG107267A (de)
BR (1)	BR0111271A (de)
CA (1)	CA2410618A1 (de)
CY (1)	CY1105992T1 (de)
CZ (1)	CZ20023860A3 (de)
DE (3)	DE60124791T2 (de)
DK (1)	DK1468686T3 (de)
DO (1)	DOP2001000181A (de)
EA (1)	EA007068B1 (de)
EC (1)	ECSP024369A (de)
EE (1)	EE200200670A (de)
ES (1)	ES2277170T3 (de)
GE (1)	GEP20053512B (de)
HN (1)	HN2001000119A (de)
HR (1)	HRP20020953A2 (de)
HU (1)	HUP0301747A2 (de)
IL (2)	IL152782A0 (de)
IS (1)	IS6619A (de)
MA (1)	MA26908A1 (de)
MX (1)	MXPA02011862A (de)
NO (1)	NO325077B1 (de)
NZ (1)	NZ551012A (de)
OA (1)	OA12267A (de)
PA (1)	PA8518301A1 (de)
PE (1)	PE20011329A1 (de)
PL (1)	PL365576A1 (de)
PT (2)	PT1468686E (de)
SI (1)	SI1468686T1 (de)
SK (1)	SK16622002A3 (de)
SV (1)	SV2002000473A (de)
UA (1)	UA79425C2 (de)
UY (1)	UY26742A1 (de)
WO (1)	WO2001091756A2 (de)
YU (1)	YU90702A (de)
ZA (1)	ZA200209665B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003296991A1 (en)	2002-12-13	2004-07-09	Regents Of The University Of Minnesota	Scleral depressor
CA2543805A1 (en)	2003-10-24	2005-05-06	Gideon Pilarsky	Processes for preparation of ziprasidone
ES2250001B1 (es) *	2004-09-29	2007-06-01	Medichem, S.A.	Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) *	2011-02-24	2012-09-10	Kyocera Corp	プログラム保護装置および通信装置
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
US9981041B2 (en) *	2016-08-23	2018-05-29	Ira Jason Salzman	Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW491847B (en) *	1996-05-07	2002-06-21	Pfizer	Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
US6110918A (en) *	1996-05-07	2000-08-29	Pfizer Inc	Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist
ATE247963T1 (de) *	1998-05-26	2003-09-15	Pfizer Prod Inc	Medikament zur behandlung von glaukoma und ischämischer retinopathie
WO2000059489A2 (en) *	1999-04-06	2000-10-12	Sepracor Inc.	Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites

2001
- 2001-05-28 DK DK04013380T patent/DK1468686T3/da active
- 2001-05-28 DE DE60124791T patent/DE60124791T2/de not_active Expired - Fee Related
- 2001-05-28 CN CN01810620A patent/CN1431901A/zh active Pending
- 2001-05-28 SK SK1662-2002A patent/SK16622002A3/sk not_active Application Discontinuation
- 2001-05-28 EP EP01932011A patent/EP1286672B1/de not_active Expired - Lifetime
- 2001-05-28 CA CA002410618A patent/CA2410618A1/en not_active Abandoned
- 2001-05-28 KR KR1020027016364A patent/KR20030007824A/ko not_active Ceased
- 2001-05-28 DE DE60133596T patent/DE60133596D1/de not_active Expired - Lifetime
- 2001-05-28 EA EA200201168A patent/EA007068B1/ru not_active IP Right Cessation
- 2001-05-28 CZ CZ20023860A patent/CZ20023860A3/cs unknown
- 2001-05-28 IL IL15278201A patent/IL152782A0/xx active IP Right Grant
- 2001-05-28 HR HR20020953A patent/HRP20020953A2/hr not_active Application Discontinuation
- 2001-05-28 AT AT01932011T patent/ATE343387T1/de not_active IP Right Cessation
- 2001-05-28 OA OA1200200349A patent/OA12267A/en unknown
- 2001-05-28 YU YU90702A patent/YU90702A/sh unknown
- 2001-05-28 AT AT06116051T patent/ATE391507T1/de not_active IP Right Cessation
- 2001-05-28 EP EP04013380A patent/EP1468686B1/de not_active Expired - Lifetime
- 2001-05-28 EP EP06116051A patent/EP1698338B1/de not_active Expired - Lifetime
- 2001-05-28 HU HU0301747A patent/HUP0301747A2/hu unknown
- 2001-05-28 AT AT04013380T patent/ATE345818T1/de not_active IP Right Cessation
- 2001-05-28 BR BR0111271-6A patent/BR0111271A/pt not_active Application Discontinuation
- 2001-05-28 WO PCT/IB2001/000933 patent/WO2001091756A2/en not_active Ceased
- 2001-05-28 PT PT04013380T patent/PT1468686E/pt unknown
- 2001-05-28 ES ES04013380T patent/ES2277170T3/es not_active Expired - Lifetime
- 2001-05-28 UA UA2002119557A patent/UA79425C2/uk unknown
- 2001-05-28 AU AU2001258690A patent/AU2001258690A1/en not_active Abandoned
- 2001-05-28 DE DE60124093T patent/DE60124093D1/de not_active Expired - Lifetime
- 2001-05-28 PT PT06116051T patent/PT1698338E/pt unknown
- 2001-05-28 SI SI200130681T patent/SI1468686T1/sl unknown
- 2001-05-28 JP JP2001587771A patent/JP2003534381A/ja not_active Withdrawn
- 2001-05-28 EE EEP200200670A patent/EE200200670A/xx unknown
- 2001-05-28 GE GE4972A patent/GEP20053512B/en unknown
- 2001-05-28 PL PL01365576A patent/PL365576A1/xx unknown
- 2001-05-28 MX MXPA02011862A patent/MXPA02011862A/es active IP Right Grant
- 2001-05-28 NZ NZ551012A patent/NZ551012A/en unknown
- 2001-05-31 PE PE2001000504A patent/PE20011329A1/es not_active Application Discontinuation
- 2001-05-31 UY UY26742A patent/UY26742A1/es not_active Application Discontinuation
- 2001-05-31 AP APAP/P/2001/002180A patent/AP1831A/en active
- 2001-05-31 HN HN2001000119A patent/HN2001000119A/es unknown
- 2001-05-31 DO DO2001000181A patent/DOP2001000181A/es unknown
- 2001-05-31 AP AP2005003272A patent/AP1747A/xx active
- 2001-06-01 PA PA20018518301A patent/PA8518301A1/es unknown
- 2001-06-01 SV SV2001000473A patent/SV2002000473A/es not_active Application Discontinuation
- 2001-06-01 AR ARP010102641A patent/AR028937A1/es unknown
- 2001-06-04 US US09/873,973 patent/US20060287336A1/en not_active Abandoned
2002
- 2002-11-11 IL IL152782A patent/IL152782A/en not_active IP Right Cessation
- 2002-11-12 BG BG107267A patent/BG107267A/bg unknown
- 2002-11-14 IS IS6619A patent/IS6619A/is unknown
- 2002-11-28 ZA ZA200209665A patent/ZA200209665B/en unknown
- 2002-11-29 MA MA26927A patent/MA26908A1/fr unknown
- 2002-11-29 EC EC2002004369A patent/ECSP024369A/es unknown
- 2002-11-29 NO NO20025760A patent/NO325077B1/no unknown
2007
- 2007-02-08 CY CY20071100161T patent/CY1105992T1/el unknown
- 2007-11-14 JP JP2007296039A patent/JP2008056700A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2410618A1 (en)	2001-12-06
HRP20020953A2 (en)	2005-02-28
DE60124093D1 (de)	2006-12-07
AP1747A (en)	2007-05-31
SK16622002A3 (sk)	2004-07-07
UY26742A1 (es)	2001-12-28
DOP2001000181A (es)	2002-04-15
IL152782A0 (en)	2003-06-24
EP1698338A3 (de)	2006-09-20
NO325077B1 (no)	2008-01-28
ES2277170T3 (es)	2007-07-01
AR028937A1 (es)	2003-05-28
NZ551012A (en)	2008-04-30
OA12267A (en)	2004-01-20
EP1286672B1 (de)	2006-10-25
YU90702A (sh)	2005-11-28
DK1468686T3 (da)	2007-03-12
MXPA02011862A (es)	2003-04-10
ECSP024369A (es)	2003-02-06
WO2001091756A2 (en)	2001-12-06
PE20011329A1 (es)	2002-01-15
CN1431901A (zh)	2003-07-23
EP1468686B1 (de)	2006-11-22
ATE343387T1 (de)	2006-11-15
GEP20053512B (en)	2005-05-10
AU2001258690A1 (en)	2001-12-11
JP2003534381A (ja)	2003-11-18
CY1105992T1 (el)	2011-04-06
EP1698338B1 (de)	2008-04-09
EE200200670A (et)	2004-08-16
US20060287336A1 (en)	2006-12-21
EP1286672A2 (de)	2003-03-05
PL365576A1 (en)	2005-01-10
KR20030007824A (ko)	2003-01-23
MA26908A1 (fr)	2004-12-20
UA79425C2 (en)	2007-06-25
NO20025760D0 (no)	2002-11-29
DE60133596D1 (de)	2008-05-21
IL152782A (en)	2007-10-31
SV2002000473A (es)	2002-10-24
EP1698338A2 (de)	2006-09-06
HN2001000119A (es)	2001-09-11
SI1468686T1 (sl)	2007-04-30
ATE391507T1 (de)	2008-04-15
EA200201168A1 (ru)	2003-06-26
NO20025760L (no)	2003-01-15
WO2001091756A3 (en)	2002-09-26
EA007068B1 (ru)	2006-06-30
DE60124791D1 (de)	2007-01-04
PT1698338E (pt)	2008-06-03
JP2008056700A (ja)	2008-03-13
DE60124791T2 (de)	2007-09-13
BG107267A (bg)	2003-06-30
EP1468686A3 (de)	2004-12-01
CZ20023860A3 (cs)	2004-01-14
EP1468686A2 (de)	2004-10-20
ZA200209665B (en)	2003-11-28
PA8518301A1 (es)	2002-09-17
AP1831A (en)	2008-02-26
HUP0301747A2 (hu)	2003-09-29
AP2005003272A0 (en)	2005-03-31
PT1468686E (pt)	2007-01-31
BR0111271A (pt)	2003-06-10
IS6619A (is)	2002-11-14

Legal Events

Date

Code

Title

Description

2007-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1468686

Country of ref document: EP

2010-02-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60113496D1 (de)	2006-02-02	Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
ATE275145T1 (de)	2004-09-15	Chinazolinderivate zur behandlung von tumoren
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de)	2005-05-25	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de)	2005-05-25	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60218493D1 (de)	2007-04-12	Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
DE69936335D1 (de)	2007-08-02	Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE60234760D1 (de)	2010-01-28	Phenylindole zur behandlung von hiv
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
ATE410430T1 (de)	2008-10-15	2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60019158D1 (de)	2005-05-04	Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60208221D1 (de)	2006-01-26	Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60130365D1 (de)	2007-10-18	Die Verwendung von Rosiglitazon zur Behandlung von psychiatrischen Erkrankungen.
DE60218451D1 (de)	2007-04-12	15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
ATE279386T1 (de)	2004-10-15	Retinoide zur behandlung von emphysem
DE60214355D1 (de)	2006-10-12	Exemestan zur behandlung von hormonabhängigen störungen
DE60238765D1 (de)	2011-02-10	Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de)	2005-04-28	Chlorzoxazon zur behandlung von psoriasis
ATE273276T1 (de)	2004-08-15	Cyclobutendion-derivate zur behandlung von artherosclerose
DE50205466D1 (de)	2006-02-02	Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
ATE312104T1 (de)	2005-12-15	Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
DE60021252D1 (de)	2005-08-18	Antikonvulsiva zur behandlung von autismus
ATE390134T1 (de)	2008-04-15	(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4- fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen
DE60117122D1 (de)	2006-04-20	Verwendung von mirtazapin zur behandlung von schlafstörungen
ATE230741T1 (de)	2003-01-15	3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen